FDA On “Critical Path” To Secure Support For Drug Development Project

FDA will be seeking congressional support for its "Critical Path" initiative, Acting Commissioner Lester Crawford, PhD, said April 15 at the Food & Drug Law Institute's annual conference in Washington, D.C